Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000035

Chief Financial Officer sold 7,989 shares at an average $16.78 ($134,036)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Davis Blaine Chief Financial Officer 2025-01-03 Sale −3,961 $16.72 $66,235 98,839 D: show line 1 in the form
Davis Blaine Chief Financial Officer 2025-01-06 Sale −4,028 $16.83 $67,800 94,811 D: show line 2 in the form
Open-market sales · 7,989 sh · avg $16.78 · $134,036
Loading xslF345X05/wk-form4_1736298282.xml…